Literature DB >> 17868282

The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption.

Takuhiro Matsumura1, Yingji Jin, Yuko Kabumoto, Yuki Takegahara, Keiji Oguma, Wayne I Lencer, Yukako Fujinaga.   

Abstract

The type B botulinum neurotoxin (BoNT) elicits flaccid paralysis and death in humans by intoxicating peripheral nerves after oral absorption. Here, we examine the function of the haemagglutinin (HA), a non-toxic component of the large 16S BoNT complex. We find that the HA acts in the intestine to disrupt epithelial barrier function by opening intercellular tight and adherens junctions. This allows transport of BoNT and other large solutes into the systemic circulation and explains how the type B BoNT complexes are efficiently absorbed. In vitro, HA appears to act on the epithelial cell via the basolateral membrane only, suggesting the possibility of another step in the absorptive process. These studies show that the 16S BoNT complex is a multifunctional protein assembly equipped with the machinery to efficiently breach the intestinal barrier and act systemically on peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868282     DOI: 10.1111/j.1462-5822.2007.01048.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  35 in total

Review 1.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

2.  Crystallization and preliminary crystallographic studies of the HA3 subcomponent of the type B botulinum neurotoxin complex.

Authors:  Kohsuke Nishimura; Kengo Kitadokoro; Yuki Takegahara; Yo Sugawara; Takuhiro Matsumura; Hajime Karatani; Yukako Fujinaga
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-09-29

3.  The case of botulinum toxin in milk: experimental data.

Authors:  Oliver G Weingart; Tanja Schreiber; Conny Mascher; Diana Pauly; Martin B Dorner; Thomas F H Berger; Charlotte Egger; Frank Gessler; Martin J Loessner; Marc-Andre Avondet; Brigitte G Dorner
Journal:  Appl Environ Microbiol       Date:  2010-04-02       Impact factor: 4.792

4.  The botulinum toxin complex meets E-cadherin on the way to its destination.

Authors:  Yo Sugawara; Yukako Fujinaga
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

5.  Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.

Authors:  Kwangkook Lee; Kwok-Ho Lam; Anna-Magdalena Kruel; Stefan Mahrhold; Kay Perry; Luisa W Cheng; Andreas Rummel; Rongsheng Jin
Journal:  Toxicon       Date:  2015-08-10       Impact factor: 3.033

6.  Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex.

Authors:  Sho Amatsu; Yo Sugawara; Takuhiro Matsumura; Kengo Kitadokoro; Yukako Fujinaga
Journal:  J Biol Chem       Date:  2013-10-28       Impact factor: 5.157

7.  Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan.

Authors:  Kaoru Umeda; Yoshiyuki Seto; Tomoko Kohda; Masafumi Mukamoto; Shunji Kozaki
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

8.  Analysis of the mechanisms that underlie absorption of botulinum toxin by the inhalation route.

Authors:  Fetweh H Al-Saleem; Denise M Ancharski; Suresh G Joshi; M Elias; Ajay Singh; Zidoon Nasser; Lance L Simpson
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

Review 9.  Interaction of botulinum toxin with the epithelial barrier.

Authors:  Yukako Fujinaga
Journal:  J Biomed Biotechnol       Date:  2010-02-14

10.  Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin.

Authors:  Yo Sugawara; Takuhiro Matsumura; Yuki Takegahara; Yingji Jin; Yoshikazu Tsukasaki; Masatoshi Takeichi; Yukako Fujinaga
Journal:  J Cell Biol       Date:  2010-05-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.